Reuters: Chinese Firm Hires Trump-Linked Lobbying Firm to Avoid US Regulatory Scrutiny
NQ Score
100/100
AI Summary (NQ-processed)
A Chinese pharmaceutical group, Grand Pharmaceutical Group, hired Checkmate, a lobbying firm connected to Donald Trump Jr., to navigate a US regulatory review of its $12 million investment in US startup FastWave. FastWave, which produces laser catheters, sought CFIUS review due to national security concerns and a partnership between Grand Pharmaceutical and a Chinese competitor. CFIUS ultimately rejected FastWave's application for a national security review, siding with Grand Pharmaceutical.
AI analysis data is not yet available.